People Taking Wegovy Continue to Maintain Weight Loss 4 Years Later

In a new study researchers found that people receiving Wegovy (semaglutide) lost an average of 10% of their body weight after four years. An earlier analysis of data from this trial found that semaglutide reduced the risk of heart attack, stroke and cardiovascular death in people with obesity or who are overweight.
Healthline Multiple Sclerosis
May 16, 2024
People Taking Wegovy Continue to Maintain Weight Loss 4 Years Later
 
READ ON
→
How Miss America Madison Marsh Is Working to Improve Cancer Care
 
READ ON
→
Dietitians' Picks of the 5 Best Weight Loss Programs in 2024
 
READ ON
→
How to Avoid Atopic Dermatitis Flare-Ups
 
READ ON
→
MORE STORIES
RESOURCE FOR YOU
 
 
 
 
HEALTHLINE VIDEO
My Long Road to Atopic Dermatitis
Personal stories and insights on eczema for those living with it.
WATCH NOW  →
  My Long Road to Atopic Dermatitis
 
 
 
COPD CARE TEAM BUILDER
Overall health
 
Lung health
Breathing difficulties
 
Surgery for COPD
Quitting smoking
 
Diet or nutrition
HEALTHLINE RESOURCE
 
What we're reading next
How to Avoid a Migraine Attack Before It Happens
The Link Between Ulcerative Colitis and Osteoporosis, Plus Tips for Prevention
The 9 Best Peloton Bike Alternatives of 2024
Self-Administered Gerocognitive Exam (SAGE) for Dementia
Advertisement
 
healthline
FB   Tiktok   TW   youtube   INSTA

Post a Comment

Previous Post Next Post

Contact Form